PBM, Chain Drug Summer Lobbying Focuses On Mail-Order Rx In Medicare
Chain drug stores and PBMs are trying to shape the role of retail and mail-order pharmacy in a Medicare prescription drug benefit through "grassroots" lobbying campaigns during Congress' August recess
You may also be interested in...
The White House is opposed to requiring Medicare prescription drug discount card sponsors to pass through all drug rebates and discounts to the consumer
The PBM "transparency" provision in the Senate's Medicare prescription drug bill would lead to higher monthly premiums and higher beneficiary cost-sharing, the Congressional Budget Office said
PBMs administering Medicare drug plans would be required to report all payments received from drug manufacturers to the Department of Justice and the HHS Inspector General under the Senate's Medicare legislation